Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors |
17/02/2017 |
CIM |
Study of intensive pediatric pharmacovigilance of nimotuzumab for the treatment of malignant glioma tumors. |
14/08/2014 |
CIMAB |
Study in Hematological Malignancies |
14/11/2014 |
CIGB |
Squamous cell carcinoma interferons (CECIN study) |
2013-02-01 |
CIGB |
SOBERANA PLUS TURIN |
12/11/2021 |
FINLAY |
SOBERANA PLUS |
09/04/2021 |
FINLAY |
SOBERANA PEDIATRIA |
10/06/2021 |
FINLAY |
SOBERANA 02A |
17/12/2020 |
FINLAY |
SOBERANA 02-FaseIII |
03/03/2021 |
FINLAY |
SOBERANA 02 |
27/10/2020 |
FINLAY |
SOBERANA 01B |
05/01/2021 |
FINLAY |
SOBERANA 01A |
17/10/2020 |
FINLAY |
Sinopharm-SOBERANA COVID-Cienfuegos |
30/08/2022 |
FINLAY |
Second Line-Acute Asthma |
09/07/2020 |
SAHUAPA |
Seawater-Rhinitis-Children-Phase III |
25/09/2015 |
UDEA |
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. |
2009-07-24 |
CIMAB |
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) |
2013-01-18 |
CIGB |
Safety and immunogenicity of commercial Hepatitis B vaccines. |
2009-02-27 |
CIGB |
Retrospective observational study of the administration of Jusvinza, for the management of COVID-19 at the Hospital “Dr. Luis Diaz Soto”. |
29/10/2021 |
CIGB |
Results of an antimicrobial stewardship program |
30/05/2018 |
CenQfal |